Covered recipient · General Payments record
ALBERT ASKARINAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,030.80
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $527.58 | 25 |
| Education | $8.90 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $271.26 | 14 |
| Lilly USA, LLC | $144.32 | 6 |
| Astellas Pharma US Inc | $25.10 | 1 |
| GlaxoSmithKline, LLC. | $22.87 | 1 |
| Merck Sharp & Dohme Corporation | $19.80 | 1 |
| Amgen Inc. | $18.99 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.77 | 1 |
| DEXCOM, INC. | $15.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.99 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117193237 | CMS |
| Astellas Pharma US Inc | $25.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139354733 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.77 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086216295 | CMS |
| Dexcom, Inc. | $15.37 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153277088 | CMS |
| GlaxoSmithKline, LLC. | $22.87 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116540686 | CMS |
| Lilly USA, LLC | $32.60 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015277 | CMS |
| Lilly USA, LLC | $34.46 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136009853 | CMS |
| Lilly USA, LLC | $32.24 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015279 | CMS |
| Lilly USA, LLC | $7.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135995984 | CMS |
| Lilly USA, LLC | $13.23 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136019370 | CMS |
| Lilly USA, LLC | $24.77 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015531 | CMS |
| Merck Sharp & Dohme LLC | $19.80 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141585038 | CMS |
| Novo Nordisk Inc | $16.47 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097389410 | CMS |
| Novo Nordisk Inc | $16.42 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096620840 | CMS |
| Novo Nordisk Inc | $1.72 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097505462 | CMS |
| Novo Nordisk Inc | $1.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096952432 | CMS |
| Novo Nordisk Inc | $4.14 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097199381 | CMS |
| Novo Nordisk Inc | $22.41 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097522940 | CMS |
| Novo Nordisk Inc | $19.54 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096671160 | CMS |
| Novo Nordisk Inc | $13.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096776700 | CMS |
| Novo Nordisk Inc | $8.90 | 08/14/2024 | Education | Undisputed | 01/23/2026 | 1096938353 | CMS |
| Novo Nordisk Inc | $6.28 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097758796 | CMS |
| Novo Nordisk Inc | $8.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568556 | CMS |
| Novo Nordisk Inc | $1.91 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097770634 | CMS |
| Novo Nordisk Inc | $120.85 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096623580 | CMS |
| Novo Nordisk Inc | $29.06 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096864628 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.